The New York Entrepreneur

Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpox

Read Time:6 Second

The Emergent vaccine is now the second one to win FDA approval after one developed by Danish biotech Bavarian Nordic.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post How Michael Jordan’s $15 million Chicago home landed at the center of a TikTok controversy
Next post Bond yields steady ahead of PCE inflation report